Heat Biologics Inc. (HTBX) is priced at $1.09 after the most recent trading session. At the very opening of the session, the stock price was $1.05 and reached a high price of $1.08, prior to closing the session it reached the value of $1.05. The stock touched a low price of $1.003.
Recently in News on November 9, 2020, Heat Biologics Provides Third Quarter 2020 Business Update. Continued progress on oncology and COVID-19 vaccine programs. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Heat Biologics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.3000 on 07/21/20, with the lowest value was $0.1950 for the same time period, recorded on 02/27/20.
Heat Biologics Inc. (HTBX) full year performance was 153.58%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Heat Biologics Inc. shares are logging -74.69% during the 52-week period from high price, and 458.21% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.19 and $4.30.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1236273 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Heat Biologics Inc. (HTBX) recorded performance in the market was 122.11%, having the revenues showcasing -42.35% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 160.85M, as it employees total of 36 workers.
The Analysts eye on Heat Biologics Inc. (HTBX)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.4273, with a change in the price was noted +0.3265. In a similar fashion, Heat Biologics Inc. posted a movement of +43.25% for the period of last 100 days, recording 22,937,381 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for HTBX is recording 0.01 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Heat Biologics Inc. (HTBX)
Raw Stochastic average of Heat Biologics Inc. in the period of last 50 days is set at 31.48%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 35.38%. In the last 20 days, the company’s Stochastic %K was 28.09% and its Stochastic %D was recorded 20.41%.
Considering, the past performance of Heat Biologics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 122.11%. Additionally, trading for the stock in the period of the last six months notably improved by 77.79%, alongside a boost of 153.58% for the period of the last 12 months. The shares increased approximately by -9.83% in the 7-day charts and went up by -19.47% in the period of the last 30 days. Common stock shares were lifted by -42.35% during last recorded quarter.